As of 2025-10-24, the EV/EBITDA ratio of Kymera Therapeutics Inc (KYMR) is -13.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KYMR's latest enterprise value is 4,129.84 mil USD. KYMR's TTM EBITDA according to its financial statements is -303.76 mil USD. Dividing these 2 quantities gives us the above KYMR EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 11.1x | 7.9x |
| Forward P/E multiples | 7.3x - 14.0x | 11.9x |
| Fair Price | (31.18) - (47.07) | (42.06) |
| Upside | -154.0% - -181.5% | -172.8% |
| Date | EV/EBITDA |